Charles River Laboratories (CRL) Tops Q2 EPS by 32c, Lifts Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. LYB
2. REGN
3. LITE
4. CL
5. BP
6. RELIANCE:I
7. NVT
8. OKTA
9. ABBV
10. CVX

Go back to Charles River Laboratories (CRL) Tops Q2 EPS by 32c, Lifts Guidance

Charles River Laboratories Announces Second-Quarter 2020 Results

August 5, 2020 7:00 AM EDT

Second-Quarter Revenue of $682.6 Million

Second-Quarter GAAP Earnings per Share of $1.34 and Non-GAAP Earnings per Share of $1.58

Increases 2020 Guidance

Announces Proposed Acquisition of Cellero in the High-Growth Cell Therapy Market

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the second quarter of 2020. For the quarter, revenue was $682.6 million, an increase of 3.8% from $657.6 million in the second quarter of 2019.

Acquisitions contributed 3.2% to consolidated second-quarter revenue growth. The impact of... More